Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition. [electronic resource]
Producer: 20140929Description: 793-801 p. digitalISSN:- 1558-1497
- Aged
- Aged, 80 and over
- Alzheimer Disease -- drug therapy
- Animals
- Cells, Cultured
- Cognition -- drug effects
- Cyclin-Dependent Kinase 5 -- metabolism
- Disease Models, Animal
- Female
- Hippocampus -- metabolism
- Humans
- Hypoglycemic Agents -- pharmacology
- Islet Amyloid Polypeptide -- metabolism
- Male
- Memory -- drug effects
- Mice
- Middle Aged
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Neurons -- metabolism
- Neuroprotective Agents
- Oxidative Stress
- Receptors, Islet Amyloid Polypeptide -- metabolism
- Synapsins -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.